Text Size

Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye

Daull P., Nagano T., Gros E., Feraille L., Barabino S., Garrigue J.-S.


  • 2021
  • Current Eye Research
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Drug Delivery

  • Categories

    Preclinical development

  • Affiliations

    Daull, P., Ophthalmic Innovation Center, SANTEN SAS, Evry, France; Nagano, T., Research and Development Division, SANTEN Pharmaceutical Co., Ltd, Osaka, Japan; Gros, E., Les Nertières, Allée Hector Pintus, La Gaude, France; Feraille, L., Les Nertières, Allée Hector Pintus, La Gaude, France; Barabino, S., Ocular Surface and Dry Eye Center, Ospedale L, Sacco, Italy, University of Milan, Milan, Italy; Garrigue, J.-S., Ophthalmic Innovation Center, SANTEN SAS, Evry, France

Related Publications

Review of Preclinical Outcomes of a Topical Cationic Emulsion of Cyclosporine A for the Treatment of Ocular Surface Diseases

Daull P., Baudouin C., Liang H., Feraille L., Barabino S., Garrigue J.-S.


Safety and tolerability of overdosed artificial tears by abraded rabbit corneas

Daull P., Raymond E., Feraille L., Garrigue J.-S.


Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022